Pan-cancer studies have revealed a higher frequency of recurrent alterations in cancer driver genes, including PIK3CA, APC, PTEN, and MYC, and higher overall burden of copy number alterations, including whole genome duplication in metastases compared with primary tumors [2, 3]. The gene discussed is MYC; the disease is cancer.